Akero Therapeutics and HistoIndex Present New Analyses of Phase 2b HARMONY Trial in Oral and Poster Presentations at the EASL Co

• click to rate

  Posted by Two Blokes May 10 - Filed in Stock - 3 views
  
  Analysis of EFX results with AI-based digital pathology underscores the potential value in evaluating histopathology response